Literature DB >> 18957674

Intermediacy and gene-environment interaction: the example of CHRNA5-A3 region, smoking, nicotine dependence, and lung cancer.

Sholom Wacholder, Nilanjan Chatterjee, Neil Caporaso.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18957674      PMCID： PMC2610344          DOI： 10.1093/jnci/djn380

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  40 in total

1.  Fallibility in estimating direct effects.

Authors:  Stephen R Cole; Miguel A Hernán
Journal:  Int J Epidemiol       Date:  2002-02       Impact factor: 7.196

2.  Commentary: estimating direct and indirect effects-fallible in theory, but in the real world?

Authors:  Tony Blakely
Journal:  Int J Epidemiol       Date:  2002-02       Impact factor: 7.196

3.  Marginal structural models and causal inference in epidemiology.

Authors:  J M Robins; M A Hernán; B Brumback
Journal:  Epidemiology       Date:  2000-09       Impact factor: 4.822

4.  Exacerbation of recurrent depression as a result of treatment with varenicline.

Authors:  Michael K Popkin
Journal:  Am J Psychiatry       Date:  2008-06       Impact factor: 18.112

5.  A risk allele for nicotine dependence in CHRNA5 is a protective allele for cocaine dependence.

Authors:  Richard A Grucza; Jen C Wang; Jerry A Stitzel; Anthony L Hinrichs; Scott F Saccone; Nancy L Saccone; Kathleen K Bucholz; C Robert Cloninger; Rosalind J Neuman; John P Budde; Louis Fox; Sarah Bertelsen; John Kramer; Victor Hesselbrock; Jay Tischfield; John I Nurnberger; Laura Almasy; Bernice Porjesz; Samuel Kuperman; Marc A Schuckit; Howard J Edenberg; John P Rice; Alison M Goate; Laura J Bierut
Journal:  Biol Psychiatry       Date:  2008-06-02       Impact factor: 13.382

6.  Human bronchial epithelial and endothelial cells express alpha7 nicotinic acetylcholine receptors.

Authors:  Y Wang; E F Pereira; A D Maus; N S Ostlie; D Navaneetham; S Lei; E X Albuquerque; B M Conti-Fine
Journal:  Mol Pharmacol       Date:  2001-12       Impact factor: 4.436

7.  Tobacco-specific carcinogenic nitrosamines. Ligands for nicotinic acetylcholine receptors in human lung cancer cells.

Authors:  H M Schuller; M Orloff
Journal:  Biochem Pharmacol       Date:  1998-05-01       Impact factor: 5.858

8.  New cancer susceptibility loci: population and familial risks.

Authors:  Kari Hemminki; Asta Försti; Justo Lorenzo Bermejo
Journal:  Int J Cancer       Date:  2008-10-01       Impact factor: 7.396

9.  Variation in KLK genes, prostate-specific antigen and risk of prostate cancer.

Authors:  Jiyoung Ahn; Sonja I Berndt; Sholom Wacholder; Peter Kraft; Adam S Kibel; Meredith Yeager; Demetrius Albanes; Edward Giovannucci; Meir J Stampfer; Jarmo Virtamo; Michael J Thun; Heather Spencer Feigelson; Geraldine Cancel-Tassin; Olivier Cussenot; Gilles Thomas; David J Hunter; Joseph F Fraumeni; Robert N Hoover; Stephen J Chanock; Richard B Hayes
Journal:  Nat Genet       Date:  2008-09       Impact factor: 38.330

10.  Population substructure and control selection in genome-wide association studies.

Authors:  Kai Yu; Zhaoming Wang; Qizhai Li; Sholom Wacholder; David J Hunter; Robert N Hoover; Stephen Chanock; Gilles Thomas
Journal:  PLoS One       Date:  2008-07-02       Impact factor: 3.240
View more
  12 in total

1.  Genetic variants on 15q25.1, smoking, and lung cancer: an assessment of mediation and interaction.

Authors:  Tyler J VanderWeele; Kofi Asomaning; Eric J Tchetgen Tchetgen; Younghun Han; Margaret R Spitz; Sanjay Shete; Xifeng Wu; Valerie Gaborieau; Ying Wang; John McLaughlin; Rayjean J Hung; Paul Brennan; Christopher I Amos; David C Christiani; Xihong Lin
Journal:  Am J Epidemiol       Date:  2012-02-03       Impact factor: 4.897

2.  Genetic self knowledge and the future of epidemiologic confounding.

Authors:  Tyler J VanderWeele; Tyler Vander Weele
Journal:  Am J Hum Genet       Date:  2010-08-13       Impact factor: 11.025

Review 3.  From smoking to lung cancer: the CHRNA5/A3/B4 connection.

Authors:  M R D Improgo; M D Scofield; A R Tapper; P D Gardner
Journal:  Oncogene       Date:  2010-06-28       Impact factor: 9.867

4.  The impact of gene-environment dependence and misclassification in genetic association studies incorporating gene-environment interactions.

Authors:  Sara Lindström; Yu-Chun Yen; Donna Spiegelman; Peter Kraft
Journal:  Hum Hered       Date:  2009-06-11       Impact factor: 0.444

5.  Precursors in cancer epidemiology: aligning definition and function.

Authors:  Sholom Wacholder
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-04       Impact factor: 4.254

6.  Mediating effects of smoking and chronic obstructive pulmonary disease on the relation between the CHRNA5-A3 genetic locus and lung cancer risk.

Authors:  Jian Wang; Margaret R Spitz; Christopher I Amos; Anna V Wilkinson; Xifeng Wu; Sanjay Shete
Journal:  Cancer       Date:  2010-07-15       Impact factor: 6.860

7.  Genetic variants cis-regulating Xrn2 expression contribute to the risk of spontaneous lung tumor.

Authors:  Y Lu; P Liu; M James; H G Vikis; H Liu; W Wen; A Franklin; M You
Journal:  Oncogene       Date:  2009-11-16       Impact factor: 9.867

Review 8.  The genetics of addiction-a translational perspective.

Authors:  A Agrawal; K J H Verweij; N A Gillespie; A C Heath; C N Lessov-Schlaggar; N G Martin; E C Nelson; W S Slutske; J B Whitfield; M T Lynskey
Journal:  Transl Psychiatry       Date:  2012-07-17       Impact factor: 6.222

9.  Assessing causal relationships in genomics: From Bradford-Hill criteria to complex gene-environment interactions and directed acyclic graphs.

Authors:  Sara Geneletti; Valentina Gallo; Miquel Porta; Muin J Khoury; Paolo Vineis
Journal:  Emerg Themes Epidemiol       Date:  2011-06-09

10.  Method for evaluating multiple mediators: mediating effects of smoking and COPD on the association between the CHRNA5-A3 variant and lung cancer risk.

Authors:  Jian Wang; Margaret R Spitz; Christopher I Amos; Xifeng Wu; David W Wetter; Paul M Cinciripini; Sanjay Shete
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.